| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 20/06/2012 | 12h05 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 12h04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 20/06/2012 | 09h18 | Dow Jones News | AstraZeneca Completes Acquisition of Ardea Biosciences | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 19/06/2012 | 22h58 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 13/06/2012 | 23h08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 13/06/2012 | 23h03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 12/06/2012 | 23h58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 11/06/2012 | 20h04 | Edgar (US Regulatory) | Schedule 13G | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 09/06/2012 | 01h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 05/06/2012 | 20h52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 05/06/2012 | 20h51 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 05/06/2012 | 14h30 | Marketwired | Ardea Biosciences Announces Expiration of HSR Waiting Period in Connection With Proposed Merger | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 30/05/2012 | 21h49 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 30/05/2012 | 19h36 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 30/05/2012 | 15h05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |